Susquehanna International Group’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.68M | Buy |
397,056
+47,301
| +14% | +$212K | ﹤0.01% | 6576 |
|
|
2025
Q4 | $1.32M | Sell |
349,755
-513,820
| -59% | -$999K | ﹤0.01% | 6553 |
|
|
2025
Q3 | $1.39M | Sell |
863,575
-626,097
| -42% | -$1.12M | ﹤0.01% | 6569 |
|
|
2025
Q2 | $3.26M | Buy |
1,489,672
+800,976
| +116% | +$1.23M | 0.01% | 4798 |
|
|
2025
Q1 | $744K | Buy |
+688,696
| New | +$818K | ﹤0.01% | 8004 |
|
|
2023
Q4 | – | Sell |
-70,446
| Closed | -$76.2K | – | 13353 |
|
|
2023
Q3 | $116K | Buy |
70,446
+54,984
| +356% | +$86.7K | ﹤0.01% | 10797 |
|
|
2023
Q2 | $24.3K | Buy |
+15,462
| New | +$24.8K | ﹤0.01% | 11589 |
|
|
2022
Q2 | – | Sell |
-101,554
| Closed | -$298K | – | 14070 |
|
|
2022
Q1 | $678K | Buy |
101,554
+8,091
| +9% | +$47.3K | ﹤0.01% | 8168 |
|
|
2021
Q4 | $517K | Sell |
93,463
-19,403
| -17% | -$147K | ﹤0.01% | 9115 |
|
|
2021
Q3 | $1.03M | Sell |
112,866
-125,962
| -53% | -$1.17M | ﹤0.01% | 7474 |
|
|
2021
Q2 | $2.65M | Buy |
238,828
+71,425
| +43% | +$697K | ﹤0.01% | 5303 |
|
|
2021
Q1 | $1.43M | Buy |
+167,403
| New | +$1.37M | ﹤0.01% | 6778 |
|
|
2020
Q3 | – | Sell |
-10,778
| Closed | -$32K | – | 11271 |
|
|
2020
Q2 | $32K | Buy |
+10,778
| New | +$29.2K | ﹤0.01% | 9855 |
|
|
2018
Q4 | – | Sell |
-217
| Closed | -$16.8K | – | 10489 |
|
|
2018
Q3 | $13K | Buy |
+217
| New | +$15K | ﹤0.01% | 9033 |
|
|
2018
Q1 | – | Sell |
-34
| Closed | -$9.71K | – | 10525 |
|
|
2017
Q4 | $13K | Buy |
+34
| New | +$16.4K | ﹤0.01% | 9106 |
|
|
2017
Q3 | – | Sell |
-13
| Closed | -$8.58K | – | 9990 |
|
|
2017
Q2 | $12K | Sell |
13
-1
| -7% | -$870 | ﹤0.01% | 9063 |
|
|
2017
Q1 | $13K | Sell |
14
-21
| -60% | -$34.8K | ﹤0.01% | 8768 |
|
|
2016
Q4 | $101K | Buy |
+35
| New | +$204K | ﹤0.01% | 9080 |
|
Other funds holding SLS
VCM
VPM
VFT